Profit before interest, taxes and amortization: Roivant Sciences (ROIV)

Brandmark of Roivant Sciences (ROIV)

Roivant Sciences Ltd. (ROIV) production capacities and computing centers are operating without disruption. A substantial cash reserve and a promising portfolio of immunological developments are driving asset value growth. The EBITDA trend visualization confirms financial activity, with the current level sitting around 0.00. The implementation of AI platforms to automate molecule discovery radically accelerates biotech testing, as this chart clearly demonstrates.

ROIV (roivant.com) Operating profit EBITDA history from 11/23/2025 to 11/15/2026

Summary analytical data breakdowns for Roivant Sciences Ltd. (ROIV)

- stock quotes and analyst forecast:
Price Performance Chart roivant.com|ROIV - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Roivant Sciences Ltd.|ROIV - Total Company Value
- book capitalization data:
Net Assets per Single Share Roivant Sciences|ROIV - Book Capitalization|Capitalization to Book Value Ratio roivant.com|ROIV - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Roivant Sciences Ltd.|ROIV - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Roivant Sciences Ltd|ROIV - Company Aggregate Debts|Debt to Net Assets Roivant Sciences Ltd.|ROIV - Company Long-Term Debt|Company Short-Term Loans and Borrowings Roivant Sciences|Immediate Liquidity roivant.com
- net income and valuation multiples indicators:
ROIV - Net Profit|Company Profit Forecast Roivant Sciences Ltd.|ROIV - Price to Earnings Ratio|Future Price to Earnings Roivant Sciences|ROIV - PEG Multiple|EV/EBITDA Multiple Roivant Sciences Ltd.|ROIV - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Roivant Sciences|ROIV - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months roivant.com|ROIV - Net earnings per share growth this year|Expected earnings per share trend next year Roivant Sciences Ltd.
- sales revenue and business income indicators:
ROIV - Company Revenue|Company Future Sales Roivant Sciences Ltd.|ROIV - P/S Multiple|Forward Price-to-Revenue Multiple Roivant|ROIV - Sales Growth YoY (TTM)
Summary company analytics:ROIV, roivant.com
Signature product of Roivant Corp

This metric assesses the purity of cash flow from the core business, excluding the impact of debt load and taxes. It captures the company's daily ability to generate liquidity prior to financial adjustments. For Roivant Sciences Ltd. (ROIV), this is a critical marker for the efficiency of managing external contractors (CRO/CMO). A high reliance on outsourcing makes monitoring operational profit in cash a vital cost-control tool. This chart's dynamics reveal the model's resilience to inflationary pressure.

Competitors of Roivant Sciences Ltd. (ROIV)

lilly.com (LLY) - Profit before interest, taxes and amortization|ABBV - Profit before payment of interest, taxes and amortization|AZN: Profit before payment of interest, taxes and amortization|NVS: Operating profit EBITDA|Operating profit before amortization MRK|NVO (novonordisk.com) - Operating profit EBITDA|Operating profit before amortization AMGN (Amgen Inc.)|Profit before payment of interest, taxes and amortization Pfizer Corporation (PFE)|Sanofi S.A. - Operating profit before amortization|Operating profit EBITDA BMY (Bristol Myers Squibb Company)|Operating profit before depreciation charges GSK Corp|TAK: Operating profit before deduction of amortization|Operating profit before depreciation charges Teva Pharmaceuticals (TEVA)|Dr. Reddy's (RDY) - Profit before payment of interest, taxes and amortization|VTRS (Viatris) - Profit before payment of interest, taxes and amortization|ZLAB (Zai Lab Ltd) - Operating profit EBITDA|Operating profit EBITDA Bausch Health Corp|Profit before payment of interest, taxes and amortization cosmosholdingsinc.com (COSM)